提卡格勒勒增加了外周5-HT含量,通过调节托氧化酶1的上升和调节下降的血清素载体
Yue Liu1, Ye Yuan2, Qing Zhao3
1Department of Pharmacy, the Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province 050000, China; Department of Pharmacy, Shijiazhuang People's Hospital, Shijiazhuang, Hebei Province 050026, China.
International immunopharmacology
|July 12, 2025
概括
提卡格勒罗尔通过影响其合成和新陈代谢,在老鼠中增加血清素 (5-HT). 这项研究探讨了提卡格雷勒,血清素和潜在的副作用 (如呼吸障碍) 之间的联系.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 生物化学 生物化学
背景情况:
- 提卡格雷勒是急性冠状动脉综合征的关键抗血小板药物.
- 呼吸不良是一种常见的副作用,可能与血清素 (5-HT) 有关.
- 提卡格勒洛引发性呼吸障碍的确切机制尚不清楚.
研究的目的:
- 为了研究提卡格雷勒是如何影响外周血的合成和新陈代谢.
- 探索蒂卡格勒罗剂量与大鼠中的5-HT水平之间的关系.
主要方法:
- 给老鼠服用了不同剂量的蒂卡格勒罗.
- 皮质组织和血液样本被分析为5-HT及其代谢物.
- 进行了组织病理学,免疫组织化学和基因表达 (tph1, sert).
主要成果:
- 提卡格勒显著增加了以利亚5-HT和色胺细胞的增殖.
- 它降低了5-HIAA水平和血清激素的循环,表明代谢发生了改变.
- 蒂卡格勒勒上调了TPH1和下调了SERT在阴茎中,并抑制了血小板SERT,增加了血5-HT.
结论:
- 提卡格勒罗尔通过调节大鼠的合成,运输和新陈代谢,显著改变了外围的血清激素水平.
- 研究结果表明,通过改变的5-HT通路,可能有机制将提卡格勒罗与呼吸障碍联系起来.
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
409
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
409
Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
588
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
588
Antidepressant Drugs: MAOIs and Other Agents
372
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
372
G-protein Coupled Receptors
121.5K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
121.5K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
327
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
327


![Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F63025.jpg&w=3840&q=50)